ICORECONNECT INC (ICCT)
US4509581033 - Common Stock
Taking everything into account, ICCT scores 2 out of 10 in our fundamental rating. ICCT was compared to 37 industry peers in the Health Care Technology industry. ICCT has a bad profitability rating. Also its financial health evaluation is rather negative. ICCT does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year ICCT has reported negative net income.
ICCT had a negative operating cash flow in the past year.
In the past 5 years ICCT always reported negative net income.
In the past 5 years ICCT always reported negative operating cash flow.
1.2 Ratios
The Return On Assets of ICCT (-60.69%) is worse than 75.00% of its industry peers.
With a Return On Equity value of -155.45%, ICCT is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -60.69% | ||
| ROE | -155.45% | ||
| ROIC | N/A |
ROA(3y)-99.12%
ROA(5y)-142.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ICCT's Gross Margin of 74.65% is amongst the best of the industry. ICCT outperforms 80.56% of its industry peers.
In the last couple of years the Gross Margin of ICCT has grown nicely.
The Profit Margin and Operating Margin are not available for ICCT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 74.65% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.94%
GM growth 5Y49.59%
2. Health
2.1 Basic Checks
ICCT does not have a ROIC to compare to the WACC, probably because it is not profitable.
ICCT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ICCT has more shares outstanding
The debt/assets ratio for ICCT is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -10.57, we must say that ICCT is in the distress zone and has some risk of bankruptcy.
ICCT's Altman-Z score of -10.57 is on the low side compared to the rest of the industry. ICCT is outperformed by 91.67% of its industry peers.
ICCT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -10.57 |
ROIC/WACCN/A
WACC12.83%
2.3 Liquidity
ICCT has a Current Ratio of 0.22. This is a bad value and indicates that ICCT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ICCT (0.22) is worse than 94.44% of its industry peers.
ICCT has a Quick Ratio of 0.22. This is a bad value and indicates that ICCT is not financially healthy enough and could expect problems in meeting its short term obligations.
ICCT has a Quick ratio of 0.22. This is amonst the worse of the industry: ICCT underperforms 94.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.22 | ||
| Quick Ratio | 0.22 |
3. Growth
3.1 Past
ICCT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1570.70%.
Looking at the last year, ICCT shows a decrease in Revenue. The Revenue has decreased by -1.33% in the last year.
Measured over the past years, ICCT shows a very strong growth in Revenue. The Revenue has been growing by 99.94% on average per year.
EPS 1Y (TTM)-1570.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6524.85%
Revenue 1Y (TTM)-1.33%
Revenue growth 3Y98.97%
Revenue growth 5Y99.94%
Sales Q2Q%6.15%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
ICCT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for ICCT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ICORECONNECT INC
NASDAQ:ICCT (11/22/2024, 8:00:02 PM)
After market: 0.1701 +0 (+0.06%)0.17
0 (-2.86%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.04M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -60.69% | ||
| ROE | -155.45% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 74.65% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.22 | ||
| Quick Ratio | 0.22 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-1570.7%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-1.33%
Revenue growth 3Y98.97%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y